Field Of Vision
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Cardiol. Mar 26, 2013; 5(3): 18-21
Published online Mar 26, 2013. doi: 10.4330/wjc.v5.i3.18
Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension: How can patients be better selected?
Juan C Grignola, Enric Domingo
Juan C Grignola, Department of Pathophysiology, Faculty of Medicine, University of the Republic, Montevideo 11600, Uruguay
Juan C Grignola, Pulmonary Hypertension Unit, Maciel Hospital, Ministry of the Public Health, Montevideo 11600, Uruguay
Enric Domingo, Area of the Heart, University Hospital of Vall d’Hebron, 08035 Barcelona, Spain
Enric Domingo, Department of Physiology, University Autonoma of Barcelona, Campus de Bellaterra, Barcelona 08193, Spain
Author contributions: Grignola JC collected the materials and wrote the manuscript; Domingo E discussed the topic and supervised the manuscript.
Correspondence to: Juan C Grignola, MD, PhD, Department of Pathophysiology, Faculty of Medicine, University of the Republic, Avda Italia 2876, Montevideo 11600, Uruguay. jgrig@fmed.edu.uy
Telephone: +598-2487-1515 Fax: +598-2942-7820
Received: August 23, 2012
Revised: December 21, 2012
Accepted: January 18, 2013
Published online: March 26, 2013
Processing time: 215 Days and 13.2 Hours
Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) comprises organizing thrombotic obstructions in the pulmonary arteries by nonresolving thromboemboli, formation of fibrosis and remodeling of pulmonary blood vessels. Surgical pulmonary endarterectomy (PEA) is the therapy of choice for patients with surgically accessible CTEPH, which leads to a profound improvement in hemodynamics, functional class and survival. Selecting the candidates that will benefit from surgery is still a challenging task. Criteria for surgical suitability have been described but the decision-making for or against surgical intervention remains still subjective. The optimal characterization of the reciprocal contribution of large vessel and small vessel disease in the elevation of pulmonary vascular resistance is crucial for the indication and outcome of PEA. Recently, Toshner et al intended to validate the partition resistance into small and large vessels compartments (upstream resistance: Rup) by the occlusion technique in the preoperative assessment of PEA. We discuss the advantages and disadvantages of Rup and compare it with other hemodynamic predictor to evaluate operative risk in CTEPH patients.

Keywords: Pulmonary endarterectomy, Operability, Chronic thromboembolic pulmonary hypertension, Pulmonary artery occluded pressure, Pulmonary vascular resistance